159 related articles for article (PubMed ID: 28990727)
1. Magnetic resonance imaging of the prostate and targeted biopsy, Comparison of PIRADS and Gleason grading.
Bastian-Jordan M
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):183-187. PubMed ID: 28990727
[TBL] [Abstract][Full Text] [Related]
2. In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS V.2 based score.
Jyoti R; Jina NH; Haxhimolla HZ
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):212-215. PubMed ID: 27987276
[TBL] [Abstract][Full Text] [Related]
3. Multi-parametric magnetic resonance imaging monitoring patients in active surveillance for prostate cancer: a prospective cohort study.
Elkjær MC; Andersen MH; Høyer S; Pedersen BG; Borre M
Scand J Urol; 2018 Feb; 52(1):8-13. PubMed ID: 29212392
[TBL] [Abstract][Full Text] [Related]
4. Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications.
Sathianathen NJ; Konety BR; Soubra A; Metzger GJ; Spilseth B; Murugan P; Weight CJ; Ordonez MA; Warlick CA
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):573-578. PubMed ID: 30038389
[TBL] [Abstract][Full Text] [Related]
5. Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
Schlenker B; Apfelbeck M; Armbruster M; Chaloupka M; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):165-170. PubMed ID: 30562897
[TBL] [Abstract][Full Text] [Related]
6. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
7. MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.
van de Ven WJ; Venderink W; Sedelaar JP; Veltman J; Barentsz JO; Fütterer JJ; Cornel EB; Huisman HJ
Int Urol Nephrol; 2016 Jul; 48(7):1037-45. PubMed ID: 27068817
[TBL] [Abstract][Full Text] [Related]
8. Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service.
Tsai WC; Field L; Stewart S; Schultz M
J Med Imaging Radiat Oncol; 2020 Jun; 64(3):379-384. PubMed ID: 32243728
[TBL] [Abstract][Full Text] [Related]
9. Gleason Score within Prostate Abnormal Areas Defined by Multiparametric Magnetic Resonance Imaging Did Not Vary According to the PIRADS Score.
Slaoui H; Neuzillet Y; Ghoneim T; Rouanne M; Abdou A; Lugagne-Delpon PM; Scherrer A; Radulescu C; Delancourt C; Molinié V; Lebret T
Urol Int; 2017; 99(2):156-161. PubMed ID: 28391284
[TBL] [Abstract][Full Text] [Related]
10. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
[TBL] [Abstract][Full Text] [Related]
11. "In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.
Schiavina R; Vagnoni V; D'Agostino D; Borghesi M; Salvaggio A; Giampaoli M; Pultrone CV; Saraceni G; Gaudiano C; Vigo M; Bianchi L; Dababneh H; La Manna G; Chessa F; Romagnoli D; Martorana G; Brunocilla E; Porreca A
Clin Genitourin Cancer; 2017 Jun; 15(3):417-427. PubMed ID: 28258961
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
Beksac AT; Cumarasamy S; Falagario U; Xu P; Takhar M; Alshalalfa M; Gupta A; Prasad S; Martini A; Thulasidass H; Rai R; Berger M; Hectors S; Jordan J; Davicioni E; Nair S; Haines K; Lewis S; Rastinehad A; Yadav K; Jayaratna I; Taouli B; Tewari A
J Urol; 2018 Dec; 200(6):1241-1249. PubMed ID: 30563651
[TBL] [Abstract][Full Text] [Related]
13. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer.
Felker ER; Lee-Felker SA; Feller J; Margolis DJ; Lu DS; Princenthal R; May S; Cohen M; Huang J; Yoshida J; Greenwood B; Kim HJ; Raman SS
Abdom Radiol (NY); 2016 May; 41(5):954-62. PubMed ID: 27118268
[TBL] [Abstract][Full Text] [Related]
14. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
16. Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system.
Alqahtani S; Wei C; Zhang Y; Szewczyk-Bieda M; Wilson J; Huang Z; Nabi G
Sci Rep; 2020 May; 10(1):7722. PubMed ID: 32382097
[TBL] [Abstract][Full Text] [Related]
17. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the PI-RADSv2 classification in a cohort of patients who underwent a prostate fusion biopsy.].
Rodríguez Cabello MÁ; Sanz Migueláñez JL; Méndez Rubio S; Arias Fúnez F; Garrido Abad P; Carrillo Guivernau MJ; Velasco Ruíz M; González Gordaliza C; Platas Sancho A
Arch Esp Urol; 2020 Jan; 73(1):1-10. PubMed ID: 31950917
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
20. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]